Early depth of tumor shrinkage and treatment outcomes in non-small cell lung cancer treated using Nivolumab

Conclusions Early depth of tumor shrinkage was associated with outcomes after ICI treatment. Because of its simplicity and predictive ability, early tumor shrinkage may be a promising factor for use in clinical settings. However, confirmation of our results is needed.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research